The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis

Journal Title: Electronic Physician - Year 2017, Vol 9, Issue 2

Abstract

NTRODUCTION: Cardiovascular complications are the most important cause of mortality in patients with ESKD, such as coronary artery disease, left ventricular hypertrophy, heart failure and arrhythmia. Other well-known risk factors, such as diabetes mellitus, hypertension and dyslipidemia are prevalent in ESKD, yet they are not sufficient enough to explain the high prevalence of cardiovascular mortality, hence searching for other hidden risk factors to explain this high prevalence is of an utmost importance. The aim of this study was to identify the exact mechanisms connecting HCV infection, chronic liver disease, and atherogenesis. METHODS: This case control study was done on 80 patients with chronic renal failure undergoing haemodialysis at Sheikh Zayed Specialized Hospital in Giza, Egypt in 2016. The participants were divided into four groups: a control group with HCV negative by PCR (20 patients), and three HCV Positive groups according to viral load by PCR: low, moderate and high viremia. Inclusion criteria were normal serum calcium (8.5-10.5 mg/dL), phosphorus ≤5mg/dL, PTH≤250 pg/ml, Hb 10-12 g/dL, and duration of dialysis less than two years. Data were analyzed using Chi square, t-test, Mann-Whitney U test, ANOVA, and Spearman rank correlation coefficient. RESULTS: The study showed significant increase in LVM index in hemodialysis patients with high and moderate viremia compared to low viremia (p<0.001) and to control group (p<0.001). Also, significant increase in end diastolic diameter in high and moderate viremia (p<0.001), significant difference in end systolic diameter in the high viremia group (p<0.001), significant increase in the interventricular septal thickness (p<0.002) and posterior wall thickness (p<0.002) among moderate viremia were determined. CONCLUSION: HCV has a significant effect on the development of cardiovascular diseases in the general population, and in renal disease patients on the structural level.

Authors and Affiliations

Mohamed Salah Eldin Zaki

Keywords

Related Articles

Deep venous thrombosis among diabetic patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia

BACKGROUND: Deep venous thrombosis (DVT) is a major cause of morbidity and mortality among hospitalized patients worldwide and, simultaneously, the most preventable. Studies revealed several risk factors of deep venous t...

Effect of Ultra High Frequency Mobile Phone Radiation on Human Health

INTRODUCTION: Public and occupational exposure to electromagnetic fields due to the growing trend of electronic devices may cause adverse effects on human health. This paper describes the risk of mutation and sexual trau...

Effect of periodic sildenafil dosage on intraocular pressure in patients with erectile dysfunction

BACKGROUND AND AIM: Sildenafil is used to treat erectile dysfunction but it has association with some side effects. This study was conducted with the aim of investigating the effect of duration of taking sildenafil on in...

Parents’ Oral Health Literacy and its Impact on their Children’s Dental Health Status

INTRODUCTION: Because parents play a key role in children's dental health, the aim of this study was to determine the relationship between parents' oral health literacy (OHL) and their children's dental health status in...

Factors affecting length of stay in teaching hospitals of a middle-income country

INTRODUCTION: The length of stay (LOS) in hospitals is a widely used and important criteria for evaluating hospital performance. The aim of this study was to determine factors affecting LOS in teaching hospitals of Qazvi...

Download PDF file
  • EP ID EP317814
  • DOI 10.19082/3857
  • Views 80
  • Downloads 0

How To Cite

Mohamed Salah Eldin Zaki (2017). The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis. Electronic Physician, 9(2), 3857-3861. https://europub.co.uk./articles/-A-317814